DRI Healthcare Trust Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	192.69	184.71	158.91	87.27	79.86	-
Other Revenue	1.29	2.27	7.37	5.76	1.91	-
Revenue	193.98	186.99	166.28	93.03	81.77	-
Revenue Growth (YoY)	-3.53%	12.45%	78.73%	13.78%	-	-
Gross Profit	193.98	186.99	166.28	93.03	81.77	-
Selling, General & Admin	18.95	19.97	49.64	9.19	9.6	0
Other Operating Expenses	11.82	9.13	4.11	4.29	5.41	-
Operating Expenses	140.18	140.02	146.62	74.2	57.33	0
Operating Income	53.8	46.97	19.66	18.83	24.44	-0
Interest Expense	-38.38	-34.91	-26.5	-6.63	-2.24	-
Currency Exchange Gain (Loss)	-	-	-	-	0.08	-
Other Non Operating Income (Expenses)	-	-1.58	-2.57	-1.25	-0.72	-
EBT Excluding Unusual Items	15.43	10.49	-9.41	10.95	21.56	-0
Gain (Loss) on Sale of Investments	1.09	-0.77	-	-	-	-
Gain (Loss) on Sale of Assets	-	-	110.12	-	-	-
Asset Writedown	-20.02	-15.26	-9.22	-	-	-
Other Unusual Items	-48.97	2.18	-	-	-	-
Pretax Income	-52.48	-3.36	91.5	10.95	21.56	-0
Net Income	-52.24	-3.36	91.5	10.95	21.56	-0
Net Income to Common	-52.24	-3.36	91.5	10.95	21.56	-0
Net Income Growth	-	-	735.35%	-49.20%	-	-
Shares Outstanding (Basic)	56	56	44	39	35	-
Shares Outstanding (Diluted)	56	56	45	39	35	-
Shares Change (YoY)	-0.65%	26.26%	15.63%	11.36%	-	-
EPS (Basic)	-0.93	-0.06	2.06	0.28	0.62	-
EPS (Diluted)	-0.94	-0.06	2.05	0.28	0.62	-
EPS Growth	-	-	632.14%	-54.84%	-	-
Dividend Per Share	0.385	0.340	0.300	0.300	0.167	-
Dividend Growth	16.67%	13.33%	-	79.96%	-	-
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	-
Operating Margin	27.74%	25.12%	11.83%	20.24%	29.89%	-
Profit Margin	-26.93%	-1.80%	55.03%	11.77%	26.37%	-
EBITDA	155.81	149.83	106.65	78.07	66.28	-
EBITDA Margin	80.32%	80.13%	64.14%	83.91%	81.05%	-
D&A For EBITDA	102	102.87	86.98	59.23	41.84	-
EBIT	53.8	46.97	19.66	18.83	24.44	-0
EBIT Margin	27.74%	25.12%	11.83%	20.24%	29.89%	-
Revenue as Reported	199.19	187.51	166.28	93.03	81.77	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.